Xcout Intel
Nephrogen competitors & alternatives
The 4 closest competitors and alternatives to Nephrogen among application companies — ranked by similarity to what Nephrogen actually does, not by market-cap band.
Subscribe to see Nephrogen’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Nephrogen
Nephrogen is a preclinical biotechnology company founded in 2022 and headquartered in New York, NY. The company is dedicated to developing curative genomic medicines for patients suffering from serious diseases.
Nephrogen at a glance
Nephrogen is an application company headquartered in United States. It has raised at least $2M across the 2 funding rounds on record. Its most recent funding round, Pre-Seed, raised $2M in March 2026. Xcout tracks 3 named people at Nephrogen, including Chang Hong, JD (Chief Business Officer).
Nephrogen leadership
- Chang Hong, JDChief Business Officer
- Vivek Bhalla, MDChief Medical Advisor
- Demetri MaximChief Executive Officer
Nephrogen funding rounds
At least $2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $2M | — | |
| Pre-Seed | $20,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 4 Nephrogen competitors
Ranked by semantic similarity — how close each company is to Nephrogen by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
SaaS
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Business and Productivity
Unnatural Products Inc. is a biotechnology company developing orally-delivered macrocyclic peptides to address challenging therapeutic targets.
Financial Applications
Gyroscope Therapeutics is a biotechnology company focused on developing gene therapies for retinal diseases. Headquartered in London, England, the company researches and designs advanced medical treatments for severe eye conditions.
Software
Klotho Therapeutics, Inc. is a privately held biotechnology and life sciences company headquartered in San Diego, California. Founded in 2016, the venture-backed firm specializes in the synthetic replication of the Klotho protein.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Nephrogen and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nephrogenand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →